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Figure 1 Southern blot analysis of (CTG)n-repeat expansions in
various tissues of a CDM newborn. Lane Mr, Lambda HindIII mo-
lecular-weight markers. Lanes M (muscle), U (uterus), T (thymus), S
(skin), B (brain), and H (heart), Tissues from which DNA samples
were obtained. E  expanded alleles; and N  normal alleles.
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Instability of the (CTG)n Repeat in Congenital
Myotonic Dystrophy
To the Editor:
The mutation specific for myotonic dystrophy (DM) is
an unstably expanded (CTG)n repeat in the 3
′ UTR of
the myotonin protein kinase gene (Brook et al. 1992;
Fu et al. 1992; Mahadevan et al. 1992). Expanded
(CTG)n repeats show variable size heterogeneity, as ev-
idenced by smears of expanded alleles on Southern blots
(Buxton et al. 1992; Wong et al. 1995) and by tissue-
to-tissue variability of repeat size (Anvret et al. 1993;
Ashizawa et al. 1993; Thornton et al. 1994). Patients
with the congenital form of DM (CDM) show the most
severe and unique phenotype (Harper 1989) and often
have a large expansion usually 11,000 repeats (Tsilfidis
et al. 1992; Ashizawa et al. 1994). Earlier, we studied
28 CDM infants and showed that none had any appre-
ciable smears of the expanded alleles in peripheral blood
leukocyte (PBL) DNA (Wong et al. 1995). Myring et al.
(1992) noted that smears of the expanded (CTG)n repeat
in prenatal DM samples were minimal. As to the repeat-
size mosaicism between tissues, we have reported that
the (CTG)n repeat of a CDM newborn with a 5.6-kb
expansion appeared uniform, with little or no smearing
in several different tissues (Ashizawa et al. 1993). Sim-
ilarly, two DM embryos at 10 wk gestation and a CDM
infant had no repeat-size variations between tissues
(Hecht et al. 1993; Tachi et al. 1995). In contrast, Lav-
edan et al. (1993) showed that the size of the mutant
repeat varied in different tissues obtained from a DM
fetus at 20 wk gestation. Jansen et al. (1994) reported
that a DM fetus at 12 wk gestation showed no detectable
repeat-size variability between tissues, whereas subtle
variability was detected in two newborn infants at 28
wk gestation and in another, full-term infant. Recently,
Martorell et al. (1997) studied five DM fetuses and two
DM neonates and concluded that the (CTG)n repeat–size
heterogeneity between tissues becomes detectable at
13–16 wk gestation. In an attempt to reconcile these
apparently conflicting data, we examined the mutant
repeats in our CDM patients, using a Southern blot anal-
ysis that can detect subtle size differences of the (CTG)n
repeat.
Informed consent was obtained from subjects and/or
their guardians. Genomic DNA was extracted from au-
topsy tissues of a previously reported 3-d-old child born
with CDM at 32 wk gestation (Ashizawa et al. 1993)
and from PBLs of 2 CDM infants and 11 CDM subjects
2–30 years of age. Genomic DNAs were digested with
BamHI and were subjected to Southern blot analysis
with the [32P]-pMDY1 hybridization probe, as described
elsewhere (Ashizawa et al. 1992; Fu et al. 1992). The
BamHI fragments are relatively small (1.4 kb without
expansion), so that subtle differences of the (CTG)n-re-
peat size can be detected readily when fragments are
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Figure 2 Southern blot analysis of (CTG)n-repeat expansions in
representative CDM patients of various ages. Slight size variations of
the normal alleles are due to the (CTG)n-repeat–length polymorphism.
Lane Mr, Lambda HindIII molecular-weight markers. The numbers
above the lanes show the ages of the CDM patients at the time of
sample collection; “0” indicates that the patient was a newborn. E 
expanded alleles; and N  normal alleles.
Figure 3 Correlation between size heterogeneity of expanded
(CTG)n-repeat alleles and ages of CDM patients. The repeat-size het-
erogeneity is expressed as MWR (Wong et al. 1995).
subjected to electrophoresis. To maximize resolution,we
allowed the 1.4-kb fragment to migrate 19 cm into the
gel (fig. 1). Repeat-size heterogeneity was assessed by
measuring the smear size and was expressed as the mid-
peak-width ratio (MWR), as described elsewhere (Wong
et al. 1995).
The (CTG)n-repeat size clearly differed from one tissue
to another in the 3-d-old CDM infant. The largest ex-
pansion was found in the heart (5.2 kb, or ∼1,730 re-
peats), followed by those in the uterus and skin (4.5 kb,
or ∼1,500 repeats), muscle (4.2 kb, or ∼1,400 repeats),
thymus (4.1 kb, or ∼1,370 repeats), and brain (3.6 kb,
or ∼1,200 repeats) (fig. 1). In addition to these tissue-
to-tissue differences, the mutant repeat showed size het-
erogeneity within a tissue, as evidenced by variable
smear width of the expanded allele. The smear size was
most extensive in the brain ( ), followed byMWR  2.3
those in the uterus ( ), muscle (MWR  2.0 MWR 
), skin ( ), and heart ( ) and2.0 MWR  1.7 MWR  1.6
was least prominent in the thymus ( ) (fig.MWR  1.4
1). There was no significant correlation between smear
size MWR and repeat size. In PBL DNA of the 11 CDM
subjects 2–30 years of age, the expanded BamHI frag-
ments containing the mutant (CTG)n repeat showed var-
iable but definite smears, whereas CDM infants showed
no detectable smear (fig. 2). There was a good corre-
lation between smear size MWR and age ( ,2r  .77
, ) (fig. 3). However, smear size MWRt  6.30 P ! .002
showed no correlation with the repeat size.
Our data in the CDM newborn suggest that somatic
mosaicism of the (CTG)n-repeat size is already evident
soon after birth. In the previous studies that showed
minimal or nondetectable repeat-size mosaicism, EcoRI
(Myring et al. 1992; Tachi et al. 1995) or NcoI (Ashi-
zawa et al. 1993) was used in Southern blot analyses.
Since these enzymes produce relatively large fragments
(8–10 kb for normal-size alleles), small repeat-size dif-
ferences among various tissues and subtle smears of the
expanded alleles may have been missed because of lim-
ited size resolution. Thus, in most cases, somatic insta-
bility of the (CTG)n repeat does begin prenatally, pre-
sumably at !16 wk gestation, as Martorell et al. (1997)
have suggested. Our data showed that the repeat size
was largest in the heart and smallest in the brain. This
is consistent with a previously reported pattern (Ki-
noshita et al. 1996; Martorell et al. 1997), suggesting
the presence of tissue-specific determinant(s) of somatic
instability of the (CTG)n repeat. However, in two CDM
children 4 years of age who had expansion sizes of 5.1
and 3.9 kb, the smear size was greater in the latter
( ) than in the former ( ), sug-MWR  1.7 MWR  1.2
gesting that repeat size, age, and tissue-specific factors
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are not the only determinants for somatic instability of
the (CTG)n repeat.
Heterogeneity of the (CTG)n repeat within a tissue has
been seen in skeletal muscle, brain, and kidney of a fetus
at 28 wk gestation, with ∼2,500 repeats (Martorell et
al. 1997). Interestingly, in this fetus and in our CDM
infant, the tissues containing leukocytes (blood and thy-
mus, respectively) showed little or no smearing. This is
consistent with our previous observation that PBL DNA
of CDM infants show no size heterogeneity of the repeat-
containing NcoI fragments (Wong et al. 1995). In the
present study, PBL DNA of two CDM infants showed
no detectable repeat-size heterogeneity of the BamHI
fragment, suggesting that there is, indeed, no extensive
somatic instability during the ontogenic development of
leukocytes in the prenatal period. In contrast, our CDM
patients 12 years of age showed variable but substantial
smears with a strong correlation to the patient’s age.
Although serial samples of CDM patients are currently
not available, this suggests that somatic heterogeneity of
the (CTG)n repeat observed in the blood of CDM sub-
jects is mainly a result of postnatal somatic instability.
In each CDM subject with a detectable smear in PBL,
the prenatal period was shorter than the postnatal life,
although somatic-cell replication is expected to be far
more intense during the prenatal development. Perhaps
instability of mutant repeat arrays may be time depend-
ent rather than replication dependent, in the bone-mar-
row stem-cell/PBL lineage. We conclude that somatic in-
stability of the (CTG)n repeat in CDM begins prenatally
in a tissue-dependent fashion and that the (CTG)n-re-
peat-size instability within the leukocyte lineage is min-
imal during the prenatal development but increases with
age after birth.
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Homogeneity of Kerato-Epithelin Codon 124
Mutations in Japanese Patients with Either of Two
Types of Corneal Stromal Dystrophy
To the Editor:
Granular corneal dystrophy Groenouw type 1 (CDGG1;
OMIM 121900 [http://www3.ncbi.nlm.nih.gov:80/
htbin-post/Omim/dispmim?121900]) is an autosomal
dominant form of corneal dystrophy that is character-
ized by discrete deposits of gray-white material in the
subepithelial and stromal layers of the cornea (Mannis
et al. 1997). The precise nature and source of these de-
posits are unclear. Amyloid deposits have been detected
in the corneas of older individuals with typical CDGG1
(Garner 1969; Akiya and Brown 1970). Lattice corneal
dystrophy type 1 (CDL1; OMIM 122200 [http://
www3.ncbi.nlm.nih.gov:80/htbin-post/Omim/dispmim?
122200]), which is clinically distinct from CDGG1, is
characterized by linear amyloid deposits in the subepi-
thelial and stromal layers of the cornea (Mannis et al.
1997). However, granular-lattice corneal dystrophy re-
cently has been described as having the clinical and his-
tological features of both granular and lattice corneal
dystrophies (Folberg et al. 1988, 1994; Holland et al.
1992; Rosenwasser et al. 1993). This condition has been
named “Avellino corneal dystrophy” (“ACD”; OMIM
121900 [http://www3.ncbi.nlm.nih.gov:80/htbin-post/
Omim/dispmim?121900]), because most of the affected
individuals could trace their origin to the Italian province
of Avellino (Holland et al. 1992).
Recently, four corneal disorders with autosomal dom-
inant traits, CDGG1, CDL1, ACD, and Reis-Bu¨cklers
corneal dystrophy (CDRB; OMIM 121900 [http://
www3.ncbi.nlm.nih.gov:80/htbin-post/Omim/dispmim?
121900]), have been mapped to chromosome 5q31
(Stone et al. 1994; Gregory et al. 1995; Korvatska et al.
1996; Small et al. 1996). More recently, these four cor-
neal dystrophies have all been shown to result from mu-
tations in the kerato-epithelin gene (Munier et al. 1997).
The mutations detected in Caucasian patients in Europe
were R124C, in two families with CDL1; R124H, in
two families with ACD; R555W, in one family with
CDGG1; and R555Q, in one family with CDRB. Each
of these four mutations affects the CpG dinucleotide of
an arginine codon. Kerato-epithelin genes with R124
mutations may form amyloidogenic intermediates that
precipitate in the cornea.
We have demonstrated the deposition of amyloid, a
feature of ACD, in corneal specimens from six of eight
Japanese patients with a clinical diagnosis of CDGG1
(Konishi et al. 1997). To investigate whether the high
frequency of amyloid deposition in Japanese patients
with CDGG1 is attributable to a specific mutation in
the kerato-epithelin gene or to other conditions, such as
aging, we screened kerato-epithelin genes from Japanese
patients with CDGG1, ACD, or CDL1 (primary corneal
amyloidosis).
The study subjects comprised 6 Japanese patients with
ACD (of whom 1, with recurrent disease, was the off-
spring from a consanguineous marriage), diagnosed by
histological examination; 10 patients with a clinical di-
agnosis of CDGG1 (of whom 2, with recurrent disease,
were the offspring from consanguineous marriages); and
6 patients with CDL1. None of the patients were related.
The mean age (SD) of the 6 patients with ACD was
70.5 (14.2) years, at the time of surgery, and that of
the 10 patients with CDGG1 was 50.1 (18.0) years,
at the time of their first visit to us. Individual exons
(exons 4–16) of the kerato-epithelin gene were amplified
from genomic DNA from each subject, by PCR with
primers described elsewhere (Munier et al. 1997), and
the amplification products were sequenced on both
strands. We detected a homozygous R124H
(np418GrA) mutation in the one ACD and two
CDGG1 patients with consanguineous parents and a
heterozygous R124H (np418GrA) mutation in the re-
maining five ACD and eight CDGG1 patients (fig. 1,
top). Patients with the homozygous mutation experi-
enced rapid progression of clinical manifestation and
visual deterioration at an early age and required kera-
toplasty in the 1st decade of life. These severe corneal
conditions resembled a variant of superficial granular
corneal dystrophy (Haddad et al. 1977; Owend et al.
1992; Sajjadi and Javadi 1992). A heterozygous R124C
(np417CrT) mutation was identified in the six patients
with CDL1 (fig. 1, bottom). To exclude the possibility
of contamination with mutated DNA in PCR or se-
quence-reaction mixtures, we also analyzed DNA from
control subjects, at the same time as our analysis of
patient DNA, and obtained normal nucleotide sequences
from the controls. We also screened 40 Japanese subjects
without corneal dystrophy and failed to detect any of
the mutations identified in the patients.
